APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Injection General Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Intravenous Injection General Anesthesia Drugs Market Analysis and Forecast 2026-2032

22 December 2025208 pages

Choose your research edition.

Industry ResearchIntravenous Injection General Anesthesia Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Injection General Anesthesia Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Intravenous Injection General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Injection General Anesthesia Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Injection General Anesthesia Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Intravenous Injection General Anesthesia Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Intravenous Injection General Anesthesia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Intravenous Injection General Anesthesia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Intravenous Injection General Anesthesia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Intravenous Injection General Anesthesia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Intravenous Injection General Anesthesia Drugs include Aspen Pharma, Hikma Pharmaceuticals, Maruishi, Maruishi, Piramal, AstraZeneca, AbbVie, Baxter Healthcare and B.Braun, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Intravenous Injection General Anesthesia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Intravenous Injection General Anesthesia Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Intravenous Injection General Anesthesia Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous Injection General Anesthesia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Intravenous Injection General Anesthesia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Intravenous Injection General Anesthesia Drugs sales, projected growth trends, production technology, application and end-user industry.

Intravenous Injection General Anesthesia Drugs Segment by Company

Aspen Pharma

Hikma Pharmaceuticals

Maruishi

Maruishi

Piramal

AstraZeneca

AbbVie

Baxter Healthcare

B.Braun

Fresenius-Kabi

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Hengrui

Nhwa

Lunan Pharmaceutical Group Corporation

Xi'an Libang

Yichang Humanwell

Intravenous Injection General Anesthesia Drugs Segment by Type

Propofol

Sevoflurane

Remifentanil

Etomidate

Isoflurane

Other

Intravenous Injection General Anesthesia Drugs Segment by Application

Hopitals

Clinics

Others

Intravenous Injection General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Injection General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Injection General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Injection General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Intravenous Injection General Anesthesia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Intravenous Injection General Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Injection General Anesthesia Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intravenous Injection General Anesthesia Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Propofol Major Manufacturers Table 3. Sevoflurane Major Manufacturers Table 4. Remifentanil Major Manufacturers Table 5. Etomidate Major Manufacturers Table 6. Isoflurane Major Manufacturers Table 7. Other Major Manufacturers Table 8. Global Intravenous Injection General Anesthesia Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hopitals Major Manufacturers Table 10. Clinics Major Manufacturers Table 11. Others Major Manufacturers Table 12. Intravenous Injection General Anesthesia Drugs Industry Trends Table 13. Intravenous Injection General Anesthesia Drugs Industry Drivers Table 14. Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges Table 15. Intravenous Injection General Anesthesia Drugs Industry Restraints Table 16. Global Intravenous Injection General Anesthesia Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2021-2026) Table 20. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2027-2032) Table 21. Global Intravenous Injection General Anesthesia Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2026) & (k units) Table 23. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2027-2032) & (k units) Table 24. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 25. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2027-2032) Table 26. Global Intravenous Injection General Anesthesia Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Intravenous Injection General Anesthesia Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Manufacturers (2021-2026) Table 30. Global Intravenous Injection General Anesthesia Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Intravenous Injection General Anesthesia Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Intravenous Injection General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Intravenous Injection General Anesthesia Drugs Manufacturers, Product Type & Application Table 34. Global Intravenous Injection General Anesthesia Drugs Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Intravenous Injection General Anesthesia Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Intravenous Injection General Anesthesia Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2021-2026) Table 41. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2027-2032) Table 42. Global Intravenous Injection General Anesthesia Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 44. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (k units) Table 45. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2021-2026) Table 46. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2027-2032) Table 47. Global Intravenous Injection General Anesthesia Drugs Price by Type (2021-2026) & (US$/unit) Table 48. Global Intravenous Injection General Anesthesia Drugs Price by Type (2027-2032) & (US$/unit) Table 49. Global Intravenous Injection General Anesthesia Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2021-2026) Table 53. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2027-2032) Table 54. Global Intravenous Injection General Anesthesia Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 56. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2021-2026) Table 58. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2027-2032) Table 59. Global Intravenous Injection General Anesthesia Drugs Price by Application (2021-2026) & (US$/unit) Table 60. Global Intravenous Injection General Anesthesia Drugs Price by Application (2027-2032) & (US$/unit) Table 61. Aspen Pharma Company Information Table 62. Aspen Pharma Business Overview Table 63. Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio Table 65. Aspen Pharma Recent Development Table 66. Hikma Pharmaceuticals Company Information Table 67. Hikma Pharmaceuticals Business Overview Table 68. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio Table 70. Hikma Pharmaceuticals Recent Development Table 71. Maruishi Company Information Table 72. Maruishi Business Overview Table 73. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 75. Maruishi Recent Development Table 76. Maruishi Company Information Table 77. Maruishi Business Overview Table 78. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 80. Maruishi Recent Development Table 81. Piramal Company Information Table 82. Piramal Business Overview Table 83. Piramal Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio Table 85. Piramal Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio Table 90. AstraZeneca Recent Development Table 91. AbbVie Company Information Table 92. AbbVie Business Overview Table 93. AbbVie Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio Table 95. AbbVie Recent Development Table 96. Baxter Healthcare Company Information Table 97. Baxter Healthcare Business Overview Table 98. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio Table 100. Baxter Healthcare Recent Development Table 101. B.Braun Company Information Table 102. B.Braun Business Overview Table 103. B.Braun Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio Table 105. B.Braun Recent Development Table 106. Fresenius-Kabi Company Information Table 107. Fresenius-Kabi Business Overview Table 108. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 110. Fresenius-Kabi Recent Development Table 111. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information Table 112. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview Table 113. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio Table 115. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Development Table 116. Hengrui Company Information Table 117. Hengrui Business Overview Table 118. Hengrui Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio Table 120. Hengrui Recent Development Table 121. Nhwa Company Information Table 122. Nhwa Business Overview Table 123. Nhwa Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio Table 125. Nhwa Recent Development Table 126. Lunan Pharmaceutical Group Corporation Company Information Table 127. Lunan Pharmaceutical Group Corporation Business Overview Table 128. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio Table 130. Lunan Pharmaceutical Group Corporation Recent Development Table 131. Xi'an Libang Company Information Table 132. Xi'an Libang Business Overview Table 133. Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio Table 135. Xi'an Libang Recent Development Table 136. Yichang Humanwell Company Information Table 137. Yichang Humanwell Business Overview Table 138. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio Table 140. Yichang Humanwell Recent Development Table 141. North America Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 142. North America Intravenous Injection General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 143. North America Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 144. North America Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (k units) Table 145. North America Intravenous Injection General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 146. North America Intravenous Injection General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 147. North America Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 148. North America Intravenous Injection General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 149. North America Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 150. North America Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (k units) Table 151. North America Intravenous Injection General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 152. North America Intravenous Injection General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 153. North America Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. North America Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 157. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 158. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 159. North America Intravenous Injection General Anesthesia Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 160. North America Intravenous Injection General Anesthesia Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 161. United States Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 162. Canada Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 163. Mexico Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 164. Europe Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 165. Europe Intravenous Injection General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 166. Europe Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 167. Europe Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (k units) Table 168. Europe Intravenous Injection General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 169. Europe Intravenous Injection General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 170. Europe Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 171. Europe Intravenous Injection General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 172. Europe Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 173. Europe Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (k units) Table 174. Europe Intravenous Injection General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 175. Europe Intravenous Injection General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 176. Europe Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Europe Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 180. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 181. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 182. Europe Intravenous Injection General Anesthesia Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 183. Europe Intravenous Injection General Anesthesia Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 184. Germany Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 185. France Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 186. U.K. Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 187. Italy Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 188. Russia Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 189. Spain Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 190. Netherlands Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 191. Switzerland Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 192. Sweden Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 193. Poland Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 194. China Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 195. China Intravenous Injection General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 196. China Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 197. China Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (k units) Table 198. China Intravenous Injection General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 199. China Intravenous Injection General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 200. China Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 201. China Intravenous Injection General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 202. China Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 203. China Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (k units) Table 204. China Intravenous Injection General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 205. China Intravenous Injection General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 206. Asia Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 207. Asia Intravenous Injection General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 208. Asia Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 209. Asia Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (k units) Table 210. Asia Intravenous Injection General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 211. Asia Intravenous Injection General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 212. Asia Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 213. Asia Intravenous Injection General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 214. Asia Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 215. Asia Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (k units) Table 216. Asia Intravenous Injection General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 217. Asia Intravenous Injection General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 218. Asia Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Asia Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. Asia Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. Asia Intravenous Injection General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 222. Asia Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 223. Asia Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 224. Asia Intravenous Injection General Anesthesia Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 225. Asia Intravenous Injection General Anesthesia Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 226. Japan Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 227. South Korea Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 228. India Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 229. Australia Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 230. Taiwan Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 231. Southeast Asia Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 232. SAMEA Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 233. SAMEA Intravenous Injection General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 234. SAMEA Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 235. SAMEA Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (k units) Table 236. SAMEA Intravenous Injection General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 237. SAMEA Intravenous Injection General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 238. SAMEA Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 239. SAMEA Intravenous Injection General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 240. SAMEA Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 241. SAMEA Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (k units) Table 242. SAMEA Intravenous Injection General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 243. SAMEA Intravenous Injection General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 244. SAMEA Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. SAMEA Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. SAMEA Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. SAMEA Intravenous Injection General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 248. SAMEA Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 249. SAMEA Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 250. SAMEA Intravenous Injection General Anesthesia Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 251. SAMEA Intravenous Injection General Anesthesia Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 252. Brazil Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 253. Argentina Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 254. Chile Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 255. Colombia Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 256. Peru Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 257. Saudi Arabia Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 258. Israel Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 259. UAE Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 260. Turkey Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 261. Iran Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 262. Egypt Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 263. Key Raw Materials Table 264. Raw Materials Key Suppliers Table 265. Intravenous Injection General Anesthesia Drugs Distributors List Table 266. Intravenous Injection General Anesthesia Drugs Customers List Table 267. Research Programs/Design for This Report Table 268. Authors List of This Report Table 269. Secondary Sources Table 270. Primary Sources List of Figures Figure 1. Intravenous Injection General Anesthesia Drugs Image Figure 2. Global Intravenous Injection General Anesthesia Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Injection General Anesthesia Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Propofol Image Figure 5. Sevoflurane Image Figure 6. Remifentanil Image Figure 7. Etomidate Image Figure 8. Isoflurane Image Figure 9. Other Image Figure 10. Global Intravenous Injection General Anesthesia Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Intravenous Injection General Anesthesia Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hopitals Image Figure 13. Clinics Image Figure 14. Others Image Figure 15. Global Intravenous Injection General Anesthesia Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Intravenous Injection General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 17. Global Intravenous Injection General Anesthesia Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2021-2032) Figure 20. Global Intravenous Injection General Anesthesia Drugs Sales (2021-2032) & (k units) Figure 21. Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Intravenous Injection General Anesthesia Drugs Sales YoY (2021-2032) & (k units) Figure 24. Europe Intravenous Injection General Anesthesia Drugs Sales YoY (2021-2032) & (k units) Figure 25. China Intravenous Injection General Anesthesia Drugs Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Intravenous Injection General Anesthesia Drugs Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales YoY (2021-2032) & (k units) Figure 28. Global Intravenous Injection General Anesthesia Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Intravenous Injection General Anesthesia Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2021-2032) Figure 34. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2021-2032) Figure 37. Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2021-2032) Figure 40. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2021-2032) Figure 43. North America Intravenous Injection General Anesthesia Drugs Revenue Share by Type (2021-2032) Figure 44. North America Intravenous Injection General Anesthesia Drugs Sales Share by Type (2021-2032) Figure 45. North America Intravenous Injection General Anesthesia Drugs Revenue Share by Application (2021-2032) Figure 46. North America Intravenous Injection General Anesthesia Drugs Sales Share by Application (2021-2032) Figure 47. North America Intravenous Injection General Anesthesia Drugs Revenue Share by Country (2021-2032) Figure 48. North America Intravenous Injection General Anesthesia Drugs Sales Share by Country (2021-2032) Figure 49. Europe Intravenous Injection General Anesthesia Drugs Revenue Share by Type (2021-2032) Figure 50. Europe Intravenous Injection General Anesthesia Drugs Sales Share by Type (2021-2032) Figure 51. Europe Intravenous Injection General Anesthesia Drugs Revenue Share by Application (2021-2032) Figure 52. Europe Intravenous Injection General Anesthesia Drugs Sales Share by Application (2021-2032) Figure 53. Europe Intravenous Injection General Anesthesia Drugs Revenue Share by Country (2021-2032) Figure 54. Europe Intravenous Injection General Anesthesia Drugs Sal

Scope & coverage.

Types
  • Propofol
  • Sevoflurane
  • Remifentanil
  • Etomidate
  • Isoflurane
  • Other
Applications
  • Hopitals
  • Clinics
  • Others
Companies covered
  • Aspen Pharma
  • Hikma Pharmaceuticals
  • Maruishi
  • Maruishi
  • Piramal
  • AstraZeneca
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Fresenius-Kabi
  • China National Medicines Guorui Pharmaceutical Co.,Ltd.
  • Hengrui
  • Nhwa
  • Lunan Pharmaceutical Group Corporation
  • Xi'an Libang
  • Yichang Humanwell

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Intravenous Injection General Anesthesia Drugs Market by Type
  3. 1.2.1 Global Intravenous Injection General Anesthesia Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Propofol
  5. 1.2.3 Sevoflurane
  6. 1.2.4 Remifentanil
  7. 1.2.5 Etomidate
  8. 1.2.6 Isoflurane
  9. 1.2.7 Other
  10. 1.3 Intravenous Injection General Anesthesia Drugs Market by Application
  11. 1.3.1 Global Intravenous Injection General Anesthesia Drugs Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hopitals
  13. 1.3.3 Clinics
  14. 1.3.4 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Intravenous Injection General Anesthesia Drugs Market Dynamics
  1. 2.1 Intravenous Injection General Anesthesia Drugs Industry Trends
  2. 2.2 Intravenous Injection General Anesthesia Drugs Industry Drivers
  3. 2.3 Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Intravenous Injection General Anesthesia Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Intravenous Injection General Anesthesia Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Region
  3. 3.2.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Intravenous Injection General Anesthesia Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Intravenous Injection General Anesthesia Drugs Sales by Region
  9. 3.4.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Intravenous Injection General Anesthesia Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Manufacturers
  2. 4.1.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Intravenous Injection General Anesthesia Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Intravenous Injection General Anesthesia Drugs Sales by Manufacturers
  6. 4.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Intravenous Injection General Anesthesia Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Intravenous Injection General Anesthesia Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Intravenous Injection General Anesthesia Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Intravenous Injection General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Intravenous Injection General Anesthesia Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Intravenous Injection General Anesthesia Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Intravenous Injection General Anesthesia Drugs Market CR5 and HHI
  16. 4.8.2 2025 Intravenous Injection General Anesthesia Drugs Tier 1, Tier 2, and Tier 3
5 Intravenous Injection General Anesthesia Drugs Market by Type
  1. 5.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Type
  2. 5.1.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Intravenous Injection General Anesthesia Drugs Sales by Type
  6. 5.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Intravenous Injection General Anesthesia Drugs Price by Type
6 Intravenous Injection General Anesthesia Drugs Market by Application
  1. 6.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Application
  2. 6.1.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Intravenous Injection General Anesthesia Drugs Sales by Application
  6. 6.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Intravenous Injection General Anesthesia Drugs Price by Application
7 Company Profiles
  1. 7.1 Aspen Pharma
  2. 7.1.1 Aspen Pharma Company Information
  3. 7.1.2 Aspen Pharma Business Overview
  4. 7.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio
  6. 7.1.5 Aspen Pharma Recent Developments
  7. 7.2 Hikma Pharmaceuticals
  8. 7.2.1 Hikma Pharmaceuticals Company Information
  9. 7.2.2 Hikma Pharmaceuticals Business Overview
  10. 7.2.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio
  12. 7.2.5 Hikma Pharmaceuticals Recent Developments
  13. 7.3 Maruishi
  14. 7.3.1 Maruishi Company Information
  15. 7.3.2 Maruishi Business Overview
  16. 7.3.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  18. 7.3.5 Maruishi Recent Developments
  19. 7.4 Maruishi
  20. 7.4.1 Maruishi Company Information
  21. 7.4.2 Maruishi Business Overview
  22. 7.4.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  24. 7.4.5 Maruishi Recent Developments
  25. 7.5 Piramal
  26. 7.5.1 Piramal Company Information
  27. 7.5.2 Piramal Business Overview
  28. 7.5.3 Piramal Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio
  30. 7.5.5 Piramal Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 AbbVie
  38. 7.7.1 AbbVie Company Information
  39. 7.7.2 AbbVie Business Overview
  40. 7.7.3 AbbVie Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio
  42. 7.7.5 AbbVie Recent Developments
  43. 7.8 Baxter Healthcare
  44. 7.8.1 Baxter Healthcare Company Information
  45. 7.8.2 Baxter Healthcare Business Overview
  46. 7.8.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio
  48. 7.8.5 Baxter Healthcare Recent Developments
  49. 7.9 B.Braun
  50. 7.9.1 B.Braun Company Information
  51. 7.9.2 B.Braun Business Overview
  52. 7.9.3 B.Braun Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio
  54. 7.9.5 B.Braun Recent Developments
  55. 7.10 Fresenius-Kabi
  56. 7.10.1 Fresenius-Kabi Company Information
  57. 7.10.2 Fresenius-Kabi Business Overview
  58. 7.10.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio
  60. 7.10.5 Fresenius-Kabi Recent Developments
  61. 7.11 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  62. 7.11.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
  63. 7.11.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  64. 7.11.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio
  66. 7.11.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
  67. 7.12 Hengrui
  68. 7.12.1 Hengrui Company Information
  69. 7.12.2 Hengrui Business Overview
  70. 7.12.3 Hengrui Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio
  72. 7.12.5 Hengrui Recent Developments
  73. 7.13 Nhwa
  74. 7.13.1 Nhwa Company Information
  75. 7.13.2 Nhwa Business Overview
  76. 7.13.3 Nhwa Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio
  78. 7.13.5 Nhwa Recent Developments
  79. 7.14 Lunan Pharmaceutical Group Corporation
  80. 7.14.1 Lunan Pharmaceutical Group Corporation Company Information
  81. 7.14.2 Lunan Pharmaceutical Group Corporation Business Overview
  82. 7.14.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio
  84. 7.14.5 Lunan Pharmaceutical Group Corporation Recent Developments
  85. 7.15 Xi'an Libang
  86. 7.15.1 Xi'an Libang Company Information
  87. 7.15.2 Xi'an Libang Business Overview
  88. 7.15.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio
  90. 7.15.5 Xi'an Libang Recent Developments
  91. 7.16 Yichang Humanwell
  92. 7.16.1 Yichang Humanwell Company Information
  93. 7.16.2 Yichang Humanwell Business Overview
  94. 7.16.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio
  96. 7.16.5 Yichang Humanwell Recent Developments
8 North America
  1. 8.1 North America Intravenous Injection General Anesthesia Drugs Market Size by Type
  2. 8.1.1 North America Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Intravenous Injection General Anesthesia Drugs Price by Type (2021-2032)
  5. 8.2 North America Intravenous Injection General Anesthesia Drugs Market Size by Application
  6. 8.2.1 North America Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Intravenous Injection General Anesthesia Drugs Price by Application (2021-2032)
  9. 8.3 North America Intravenous Injection General Anesthesia Drugs Market Size by Country
  10. 8.3.1 North America Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Intravenous Injection General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Intravenous Injection General Anesthesia Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Intravenous Injection General Anesthesia Drugs Market Size by Type
  2. 9.1.1 Europe Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Intravenous Injection General Anesthesia Drugs Price by Type (2021-2032)
  5. 9.2 Europe Intravenous Injection General Anesthesia Drugs Market Size by Application
  6. 9.2.1 Europe Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Intravenous Injection General Anesthesia Drugs Price by Application (2021-2032)
  9. 9.3 Europe Intravenous Injection General Anesthesia Drugs Market Size by Country
  10. 9.3.1 Europe Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Intravenous Injection General Anesthesia Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Intravenous Injection General Anesthesia Drugs Market Size by Type
  2. 10.1.1 China Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Intravenous Injection General Anesthesia Drugs Price by Type (2021-2032)
  5. 10.2 China Intravenous Injection General Anesthesia Drugs Market Size by Application
  6. 10.2.1 China Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Intravenous Injection General Anesthesia Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Intravenous Injection General Anesthesia Drugs Market Size by Type
  2. 11.1.1 Asia Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Intravenous Injection General Anesthesia Drugs Price by Type (2021-2032)
  5. 11.2 Asia Intravenous Injection General Anesthesia Drugs Market Size by Application
  6. 11.2.1 Asia Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Intravenous Injection General Anesthesia Drugs Price by Application (2021-2032)
  9. 11.3 Asia Intravenous Injection General Anesthesia Drugs Market Size by Country
  10. 11.3.1 Asia Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Intravenous Injection General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Intravenous Injection General Anesthesia Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Intravenous Injection General Anesthesia Drugs Market Size by Type
  2. 12.1.1 SAMEA Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Intravenous Injection General Anesthesia Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Intravenous Injection General Anesthesia Drugs Market Size by Application
  6. 12.2.1 SAMEA Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Intravenous Injection General Anesthesia Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Intravenous Injection General Anesthesia Drugs Market Size by Country
  10. 12.3.1 SAMEA Intravenous Injection General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Intravenous Injection General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Intravenous Injection General Anesthesia Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Intravenous Injection General Anesthesia Drugs Value Chain Analysis
  2. 13.1.1 Intravenous Injection General Anesthesia Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Intravenous Injection General Anesthesia Drugs Production Mode & Process
  6. 13.2 Intravenous Injection General Anesthesia Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Intravenous Injection General Anesthesia Drugs Distributors
  9. 13.2.3 Intravenous Injection General Anesthesia Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst